Convened by the International Diabetes Federation (IDF) Task Force on Epidemiology and Prevention of Diabetes, the two-day summit will develop recommendations to address increasing evidence that obstructive sleep apnoea (OSA) – a condition where snorers stop breathing during sleep, and lesser disturbances of sleep patterns - may lead to type 2 diabetes and worsen the health of those with existing diabetes.
The summit is the first high-level international meeting to focus on the association between diabetes and sleep. Delegates will evaluate the latest research and develop a consensus statement that will contribute to world health policy on diabetes, improve care for people with diabetes and sleep disorders and recommend future research directions.
The conference is co-chaired by Senior Research Investigator in the Division of Medicine at Imperial College, London, and advisor to the Blair Government on Emergency Care and former President of IDF, Professor Sir George Alberti and Director of the International Diabetes Institute and Professor of Diabetes at Monash University, Melbourne, Professor Paul Zimmet AO.
“The world is in the grip of a type 2 diabetes epidemic,” Professor Alberti said. “It is a disease that is commonly associated with obesity and cardiovascular disease. OSA also is often present among people with these conditions and is known to increase the risks that lead to heart attacks.
“The findings of the summit will assist health professionals in their approaches to prevention, diagnosis and treatment of OSA and diabetes, and assist the direction of future research efforts.”
Professor Zimmet said that more than 7% of Australian adults have type 2 diabetes and the number is expected to increase as many of the 16% of adults with prediabetes go on to develop diabetes.
“People with type 2 diabetes should consider they may have, or be at risk of sleep apnoea,” he said. “It is likely that more than half of the people with type 2 diabetes suffer from some form of sleep disordered breathing and up to a third have OSA at a level where treatment would be recommended”.
“Recent research indicates that untreated sleep apnoea may make diabetes medications less effective.
“It is well recognised that treatment with continuous positive airway pressure (CPAP) to promote breathing during sleep improves outcomes for people with OSA and cardiovascular disease.
“It is hoped these benefits may be extended to diabetes outcomes as emerging evidence shows that CPAP may improve symptoms of diabetes and the efficacy of drug treatment.”
In addition, Professor Zimmet said that sleep disturbances could affect work performance and there were growing workplace safety issues in the transport and engineering industries.
Kate McEvoy | alfa
Rabies viruses reveal wiring in transparent brains
19.01.2017 | Rheinische Friedrich-Wilhelms-Universität Bonn
On track to heal leukaemia
18.01.2017 | Universitätsspital Bern
An important step towards a completely new experimental access to quantum physics has been made at University of Konstanz. The team of scientists headed by...
Yersiniae cause severe intestinal infections. Studies using Yersinia pseudotuberculosis as a model organism aim to elucidate the infection mechanisms of these...
Researchers from the University of Hamburg in Germany, in collaboration with colleagues from the University of Aarhus in Denmark, have synthesized a new superconducting material by growing a few layers of an antiferromagnetic transition-metal chalcogenide on a bismuth-based topological insulator, both being non-superconducting materials.
While superconductivity and magnetism are generally believed to be mutually exclusive, surprisingly, in this new material, superconducting correlations...
Laser-driving of semimetals allows creating novel quasiparticle states within condensed matter systems and switching between different states on ultrafast time scales
Studying properties of fundamental particles in condensed matter systems is a promising approach to quantum field theory. Quasiparticles offer the opportunity...
Among the general public, solar thermal energy is currently associated with dark blue, rectangular collectors on building roofs. Technologies are needed for aesthetically high quality architecture which offer the architect more room for manoeuvre when it comes to low- and plus-energy buildings. With the “ArKol” project, researchers at Fraunhofer ISE together with partners are currently developing two façade collectors for solar thermal energy generation, which permit a high degree of design flexibility: a strip collector for opaque façade sections and a solar thermal blind for transparent sections. The current state of the two developments will be presented at the BAU 2017 trade fair.
As part of the “ArKol – development of architecturally highly integrated façade collectors with heat pipes” project, Fraunhofer ISE together with its partners...
19.01.2017 | Event News
10.01.2017 | Event News
09.01.2017 | Event News
19.01.2017 | Earth Sciences
19.01.2017 | Life Sciences
19.01.2017 | Physics and Astronomy